Pulmonary artery banding in dilative cardiomyopathy of young children: review and protocol based on the current
Dietmar Schranz1, Sabine Recla1, Ivan Malcic2
1Pediatric Heart Center Justus-Liebig University Giessen, Giessen, Germany.
Insights
Pulmonary artery banding (PAB) can improve left ventricular (LV) function in infants with dilated cardiomyopathy (DCM) by altering ventricular-ventricular interactions (VVI). This approach offers a potential therapeutic alternative to heart transplantation (HTx) for pediatric heart failure.
Area of Science:
- Pediatric Cardiology
- Cardiac Surgery
- Regenerative Medicine
Background:
- Dilated cardiomyopathy (DCM) is a primary cause of pediatric cardiac death, with current treatments focusing on congestive heart failure (CHF) symptoms.
- Cardiac regeneration potential in pediatric DCM, especially in infants, is often overlooked, leaving heart transplantation (HTx) as the sole life-saving but palliative option.
- Existing therapeutic strategies for heart failure are limited, often neglecting the interplay between ventricular functions beyond basic hemodynamic parameters.
Purpose of the Study:
- To propose a paradigm shift in pediatric heart failure treatment by modifying ventricular afterload through improved contra-lateral ventricular function.
- To highlight the therapeutic potential of adverse ventricular-ventricular interactions (VVI) for functional recovery in pediatric DCM.
- To review the perioperative management of reconstructive pulmonary artery banding (rPAB) as a strategy for functional recovery in pediatric DCM.
Main Methods:
- Surgical placement of pulmonary artery banding (PAB) in infants and young children with left ventricular DCM and preserved right ventricular function.
- Utilizing VVI to improve left ventricular (LV) function.
- Review of current perioperative treatment protocols enabling the use of rPAB for functional recovery.
Main Results:
- It is hypothesized that functional recovery can be achieved in nearly 80% of infants with LV-DCM, even those listed for orthotopic HTx.
- rPAB can improve LV function via VVI in pediatric patients with LV-DCM.
- This strategy can be implemented in centers without HTx capabilities.
Conclusions:
- Pulmonary artery banding (PAB) offers a viable therapeutic alternative for pediatric DCM, potentially leading to functional recovery.
- Harnessing ventricular-ventricular interactions (VVI) through rPAB represents a significant advancement in treating pediatric heart failure.
- Further research is needed to elucidate the mechanisms of PAB-induced ventricular crosstalk and its modulation.
Abstract:
Dilated cardiomyopathy (DCM) is a leading cause of cardiac death in children. Current therapeutic strategies are focused on improving symptoms of congestive heart failure (CHF); the potentials of cardiac regeneration especially in infants and young children are neglected in particular when DCM is classified as "end-stage". Heart transplantation (HTx) serves as the only life-saving option, despite is palliative character with limited survival time. Therapeutic alternatives are strongly needed, but already existing though less used; presupposed, that cardiac dysfunction and its treatment are not reduced to the four components of heart rate (rhythm), myocardial contractility, preload and afterload. A paradigm shift in the treatment of pediatric heart failure can be achieved by modifying ventricular afterload with improving contra-lateral ventricular function. Adverse ventricular-ventricular interactions (VVI) have the potential to harness them for therapeutic benefit. Surgical placement of a pulmonary artery banding (PAB) utilized in infants and young children with LV-DCM and preserved RV function are able to improve LV function via VVI; it is hypothesized, that functional recovery can be achieved in almost 80% especially of infants with LV-DCM despite criteria for listing to orthotopic HTx. The review summarizes details of the current perioperative treatment enabling each pediatric heart center to utilize rPAB as a strategy for functional recovery, even in centers without the option for Htx. Of course, future studies are needed to delineate the geometrical, temporal and molecular mechanisms of PA-banding-induced ventricular crosstalk and to examine their potential modulation through mechanical, electrophysiological and pharmacological interventions, but our patients are born, now.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Band Theory
The energy difference between these bands is known as the band gap.
Conductor, Semiconductor,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Cardiomyopathy IV: Restrictive Cardiomyopathy


